Complete withdrawal of immunosuppression in kidney allograft recipients: A prospective study in rhesus monkeys

Transplantation

Volumn 66, Issue 7, 1998, Pages 925-927

  Jonker, Margreet ^a   Van De Hout, Yvon ^a   Neuhaus, Peter ^b   Ringers, Jan ^c   Kuhn, Eva M ^a   Bruijn, Jan Anthonie ^c   Noort, Riet ^a   Doxiadis, Gaby ^a   Otting, Nel ^a   Bontrop, Ronald E ^a   Claas, Frans H J ^c   Van Rood, Jon J ^c  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b HUMBOLDT UNIVERSITY   (Germany)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; HLA DR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; DRUG WITHDRAWAL; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHESUS MONKEY;

ANIMALS; BLOOD TRANSFUSION; CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; HLA-DR ANTIGENS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MACACA MULATTA; POSTOPERATIVE CARE; PREOPERATIVE CARE; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032532532     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810150-00019     Document Type: Article

References (12)

1. Leonard AA, Jonker M, Lagaaij EM. Complete withdrawal of immunosuppression in allograft recipients: a study in rhesus monkeys. Transplantation 1996; 61: 1648.
2. Borleffs JCC, Neuhaus P, Balner H. Cyclosporin A as optimal immunosuppressant after kidney allografting in rhesus monkeys. Heart Transplant 1983; II: 111.
3. Schuurman HJ, Hengy JC, Ringers J, Vonderscher J, Schuler W, Jonker M. Neoral pharmacokinetics in cynomolgus monkeys: relation to efficacy in renal allografting. Transplant Proc, 1996; 28(6): 31.
4. Solez K, Axelsen RA, Benediktsson H. International standardisation of criteria for histological diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
5. Knapp AL, Cadavid LF, Eberle ME, Knechtle SJ, Bontrop RE, Watkins DI. Identification of new Mamu-DRB alleles using DGGE and direct sequencing. Immunogenetics 1997; 45: 171.
6. Borleffs JCC, Marquet R, Balner H. Pretransplant blood transfusions have an additive positive effect on kidney graft prognosis in D/DR matched rhesus monkeys. Transplantation 1981; 32: 48.
7. Lagaaij EM, Henneman IPH, Ruigrok MB, et al. Effect of one HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701.
8. Bayle F, Masson D, Zaoui P, et al. Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. Transplantation 1995; 59: 719.
9. Van der Mast BJ, Balk AHMM. Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation. Transplantation 1997; 63: 1514.
10. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 1993; 25: 3337.
11. Mazeriegos GV, Reyes J, Marino IR, et al. Weaning of immuno-suppression in liver transplant recipients. Transplantation 1997; 63: 243.
12. Roger JH, Vreeswijk Wvan, Balner H. The major histocompatibility complex of rhesus monkeys. XIII. Current knowledge of DR and other B-cell specific antigens. J Immunogenet 1980; 7: 333.